Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
Top Cited Papers
Open Access
- 1 October 2013
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (19), 10435-10446
- https://doi.org/10.1128/jvi.01715-13
Abstract
Current influenza virus vaccines contain H1N1 (phylogenetic group 1 hemagglutinin), H3N2 (phylogenetic group 2 hemagglutinin), and influenza B virus components. These vaccines induce good protection against closely matched strains by predominantly eliciting antibodies against the membrane distal globular head domain of their respective viral hemagglutinins. This domain, however, undergoes rapid antigenic drift, allowing the virus to escape neutralizing antibody responses. The membrane proximal stalk domain of the hemagglutinin is much more conserved compared to the head domain. In recent years, a growing collection of antibodies that neutralize a broad range of influenza virus strains and subtypes by binding to this domain has been isolated. Here, we demonstrate that a vaccination strategy based on the stalk domain of the H3 hemagglutinin (group 2) induces in mice broadly neutralizing anti-stalk antibodies that are highly cross-reactive to heterologous H3, H10, H14, H15, and H7 (derived from the novel Chinese H7N9 virus) hemagglutinins. Furthermore, we demonstrate that these antibodies confer broad protection against influenza viruses expressing various group 2 hemagglutinins, including an H7 subtype. Through passive transfer experiments, we show that the protection is mediated mainly by neutralizing antibodies against the stalk domain. Our data suggest that, in mice, a vaccine strategy based on the hemagglutinin stalk domain can protect against viruses expressing divergent group 2 hemagglutinins.This publication has 47 references indexed in Scilit:
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityProceedings of the National Academy of Sciences of the United States of America, 2012
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 virusesProceedings of the National Academy of Sciences of the United States of America, 2012
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A VirusesScience, 2011
- Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A AntibodiesClinical Infectious Diseases, 2011
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infectionThe Journal of Experimental Medicine, 2011
- Antibody Recognition of a Highly Conserved Influenza Virus EpitopeScience, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007